GlassScriptPhysician profile
Tina Cutone
NPI 1598841645
$2,190.05
in general payments reported to CMS, 2019-2025
34 companies · $722 in 2025
The $722 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $202 · 2021: $15.32 · 2022: $416 · 2023: $263 · 2024: $334 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,319.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $301.29 | 2019-2025 | Veozah |
| Novo Nordisk INC | $239.16 | 2020-2025 | Wegovy |
| Boston Scientific Corporation | $238.31 | 2019-2025 | Axonics |
| Amgen INC. | $222.52 | 2019-2025 | Evenity |
| Medtronic, INC. | $177.48 | 2022 | |
| Organon LLC | $116.91 | 2021-2025 | Nexplanon |
| Pfizer INC. | $73.46 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.59 | 2019-2024 | |
| Daiichi Sankyo INC. | $66.56 | 2019-2024 | Injectafer |
| Mayne Pharma Commercial LLC | $66.41 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $57.08 | 2023-2025 | Gemtesa, Myfembree |
| Inari Medical, INC. | $55.47 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sage Therapeutics, LLC | $54.58 | 2025 | Zurzuvae |
| Abbvie INC. | $51.30 | 2020-2025 | |
| Exact Sciences Corporation | $38.21 | 2025 | The Cologuard Plus Collection Kit |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $34.72 | 2022-2024 | Paragard T 380a |
| Radius Health, INC. | $34.54 | 2020-2022 | |
| Therapeuticsmd, INC. | $31.83 | 2019 | |
| Amag Pharmaceuticals, INC. | $30.04 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $26.40 | 2019-2020 | |
| Vivus LLC | $19.99 | 2023 | Qsymia |
| Ethicon US, LLC | $19.82 | 2025 | Vicryl |
| Coloplast Corp | $19.43 | 2024 | |
| Agile Therapeutics, INC. | $16.68 | 2023 | Twirla |
| Vertical Pharmaceuticals, LLC | $15.10 | 2019 | |
| Axonics, INC. | $14.69 | 2023 | Axonics |
| Scynexis, INC. | $14.40 | 2022 | |
| Conmed Corporation | $13.77 | 2023 | Airseal |
| Merck Sharp & Dohme LLC | $13.41 | 2019 | |
| Hologic Sales and Service, LLC | $13.22 | 2024 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Abbott Laboratories | $12.69 | 2023 | Freestyle Libre 3 |
| Medtronic USA, INC. | $12.18 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $11.64 | 2019 | |
| Meditrina | $9.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tina Cutone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.